0001209191-16-095844.txt : 20160204
0001209191-16-095844.hdr.sgml : 20160204
20160204185331
ACCESSION NUMBER: 0001209191-16-095844
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160202
FILED AS OF DATE: 20160204
DATE AS OF CHANGE: 20160204
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 161389826
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-02-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
SVP & Corp Controller
Common Stock
2016-02-02
4
A
0
6875
0.01
A
21812
D
Common Stock
2016-02-03
4
S
0
2300
89.96
D
19512
D
Common Stock
2016-02-03
4
S
0
1900
91.07
D
17612
D
Common Stock
2016-02-03
4
S
0
662
92.43
D
16950
D
Common Stock
2016-02-03
4
S
0
200
93.06
D
16750
D
Common Stock
169
I
401(k)
Stock Option (Right to Buy)
91.05
2016-02-02
4
A
0
20625
0.00
A
2026-02-01
Common Stock
20625
20625
D
Restricted stock grant vesting on 2/2/2019, subject to acceleration if certain financial and/or business metrics are achieved.
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $89.96 (range $89.54 to $90.44).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $91.07 (range $90.56 to $91.48).
Open market sales reported on this line occurred at a weighted average price of $92.43 (range $91.79 to $92.72).
Open market sales reported on this line occurred at a weighted average price of $93.06 (range $92.98 to $93.14).
The option vests in 16 quarterly installments from 02/02/2016.
Omar White, Attorney-In-Fact
2016-02-04